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ABSTRACT Junctional adhesion molecule-C (JAM-C)
is an adhesion molecule expressed at junctions between
adjacent endothelial and epithelial cells and implicated in
multiple inflammatory and vascular responses. In addi-
tion, we recently reported on the expression of JAM-C in
Schwann cells (SCs) and its importance for the integrity
and function of peripheral nerves. To investigate the role
of JAM-C in neuronal functions further, mice with a
specific deletion of JAM-C in SCs (JAM-C SC KO) were
generated. Compared to wild-type (WT) controls, JAM-C
SC KO mice showed electrophysiological defects, muscu-
lar weakness, and hypersensitivity to mechanical stimuli.
In addressing the underlying cause of these defects,
nerves from JAM-C SC KO mice were found to have
morphological defects in the paranodal region, exhibiting
increased nodal length as compared to WTs. The study
also reports on previously undetected expressions of
JAM-C, namely on perineural cells, and in line with
nociception defects of the JAM-C SC KO animals, on
finely myelinated sensory nerve fibers. Collectively, the
generation and characterization of JAM-C SC KO mice
has provided unequivocal evidence for the involvement of
SC JAM-C in the fine organization of peripheral nerves
and in modulating multiple neuronal responses.—Colom,
B., Poitelon, Y., Huang, W., Woodfin, A., Averill, S., Del
Carro, U., Zambroni, D., Brain, S. D., Perretti, M., Ahlu-
walia, A., Priestley, J. V., Chavakis, T., Imhof, B. A., Feltri,
M. L., Nourshargh, S. Schwann cell-specific JAM-C-defi-
cient mice reveal novel expression and functions for
JAM-C in peripheral nerves. FASEB J. 26, 1064–1076
(2012). www.fasebj.org
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Junctional adhesion molecule-C (JAM-C) is a type I
transmembrane protein and member of an immuno-
globulin subfamily currently composed of JAM-A,
JAM-B, JAM-C, JAM-4, JAM-L, ESAM (endothelial cell
selective adhesion molecule) and CAR (coxsackie virus
and adenovirus receptor). The molecule consists of 2
extracellular immunoglobulin domains and a short
cytoplasmic tail, which supports extracellular and intra-
cellular interactions with surface ligands and cytoskel-
etal/signaling partners, respectively (1, 2). The princi-
pal JAM-C ligands to date are JAM-C, JAM-B, and the
integrin M2, although their relative contributions to
the diverse functions of JAM-C (see below) remain
unclear (3–6). JAM-C was originally detected on endo-
thelial cells (ECs; ref. 7) and on human activated T cells
(6) and has since been reported to be expressed on
other subsets of human leukocytes (4, 8) and platelets
(3), vascular smooth muscle cells (9), and a wide range
of nonvascular cells, such as spermatids (10), epithelial
cells (11), and fibroblasts (12). In addition, we have
reported recently on the expression of JAM-C in pe-
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ripheral nerves, where it is localized on Schwann cells
(SCs) at sites characteristic of junctional regions of
noncompact myelin, such as the paranodal regions,
Schmidt-Lanterman incisures (SLIs), and the mesax-
onal regions (13).
In line with its broad expression pattern, JAM-C has
been associated with numerous biological functions.
Most notably, JAM-C has been studied in the context of
vascular and inflammatory responses, where direct evi-
dence indicates its involvement in leukocyte transmi-
gration (14), vascular permeability (15), and angiogen-
esis (16). Although much of these early works were
performed using in vitro assays, more recently the role
of JAM-C in inflammation and vascular biology has
been investigated in vivo within numerous disease mod-
els. These include murine models of arthritis, acute
pancreatitis, peritonitis, ischemia/reperfusion injury,
atherosclerosis, and pulmonary inflammation (17–22),
with some of these studies involving the use of geneti-
cally modified animals. Characterization of JAM-C-
knockout (KO) mice has also identified additional
functions for JAM-C, such as roles in cell polarity,
immunity, and inflammation (10, 19, 23). As a result of
its multiple and wide-ranging biological roles, mice
with complete deletion of JAM-C exhibit a severe
phenotype that includes growth retardation, develop-
ment of megaoesophagus, defects in hematopoiesis
(17, 24), and defective motor functions and abnormal-
ities in neural morphology and electrophysiology (13).
Collectively, the findings of the latter study indicated an
important role for JAM-C in maintaining the integrity
and function of peripheral nerves and suggested an
association between defective expression of JAM-C and
pathogenesis of inherited and/or acquired peripheral
neuropathies. However, as the severe and complex
phenotype of the complete JAM-C-KO mice makes the
study of the functional role of JAM-C in nerves difficult,
to extend our previous works we now report on the
generation and investigations of a novel mouse colony
in which the expression of JAM-C is selectively deleted
in SCs. Nerves from these animals exhibited mild
morphological and functional defects and behavioral
tests revealed muscle weakness and hypersensitivity to
mechanical nociceptive stimuli. The findings of the
present study also report on previously unknown ex-
pressions of JAM-C in peripheral nerves, specifically in
finely myelinated sensory fibers and at cell–cell junc-
tions of perineural cells. Overall, through the genera-
tion and characterization of a novel conditional-KO
mouse colony with SC-specific deletion of JAM-C, the
findings of this study provide greater insight into the
expression and function of JAM-C in peripheral nerves.
MATERIALS AND METHODS
Antibodies
Antibodies used in this study are listed in Table 1. For double
or triple staining, some antibodies were directly conjugated
with Alexa dyes using the Alexa-Fluor monoclonal antibody
labeling kits (Invitrogen, Carlsbad, CA, USA). Otherwise,
appropriate Alexa fluorescently labeled secondary antibodies
were used (Invitrogen).
TABLE 1. Antibodies used for immunofluorescence staining and Western blotting
Antigen Species Use Clone Source
JAM-C Rabbit IF, WB pAb, 322501 B.A.I. (16)
JAM-C Rat IF, WB mAb, H33 B.A.I. (7)
JAM-C Rat IF, WB mAb, H36 B.A.I. (7)
JAM-A Rat IF mAb, BV11 Elisabetta Dejana (Istituto Fondazione Italiana per
la Ricerca sul Cancro di Oncologia Molecolare,
Milan, Italy; ref. 50)
Claudin-19 Rabbit IF, WB pAb Alan S. Yu (University of Southern California, Los
Angeles, CA, USA; ref. 51)
Caspr Rabbit WB pAb Elior Peles (Department of Molecular Cell
Biology, Weizmann Institute of Science,
Rehovot, Israel; ref. 52)
VE-Cadherin Rat IF mAb, BV14 eBiosciences (San Diego, CA, USA)
E-Cadherin Rat IF, WB mAb, ECCD-2 Invitrogen (Carlsbad, CA, USA)
Claudin-1 Rabbit WB pAb Invitrogen
Mupp-1 Rabbit WB pAb Invitrogen
-SMA Mouse IF mAb, 1A4 Sigma-Aldrich (St. Louis, MO, USA)
Laminin 2 Rat IF mAb, 4H8-2 Sigma-Aldrich
-Tubulin Mouse WB mAb, TUB 2.1 Sigma-Aldrich
PanNav Mouse IF mAb, K58/35 Sigma-Aldrich
Neurofilament-M Rabbit WB pAb Millipore (Bedford, MA, USA)
L1 Rat IF mAb, 324 Millipore
Myelin P0 Rabbit WB pAb Abcam (Cambridge, UK)
Collagen IV Rabbit IF pAb Abcam
CGRP Rabbit IF pAb Biomol (Exeter, UK)
Kv1.1 Rabbit IF pAb Alomone Labs (Jerusalem, Israel)
IF, immunofluorescence staining; mAb, monoclonal antibody; pAb, polyclonal antibody; WB, Western blotting.
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Animals
JAM-C SC KO mice (P0Cre;JAM-Cf/f) were generated by
crossing JAM-C floxed mice (JAM-Cf/f; ref. 25) with P0Cre
transgenic mice (26) and maintained on a mixed 129Sv:
C57BL/6 background. JAM-Cf/f littermates were used as
controls for JAM-C SC KO mice. Transient receptor potential
cation channel V1 (TRPV1)/ mice were obtained from
The Jackson Laboratory (Bar Harbor, ME, USA). JAM-C
complete deficient mice (JAM-C/, on a 129Sv:C57BL/6
background) were obtained as gift from Dr. Ralf Adams
(Max-Planck-Institute for Molecular Biomedicine, Mu¨nster,
Germany) and generated as previously detailed (10). WT
C57BL/6 mice were obtained from Harlan-Olac (Bicester,
UK). Animal experiments were conducted in accordance with
the UK legislation.
Western blotting
Tissues were homogenized in RIPA buffer using the Pre-
cellys24 beat-beading system (Bertin Technologies, France).
Samples were resolved on 10% polyacrilamide SDS-PAGE gels
and electrotransferred onto PVDF membranes (Millipore,
Bedford, MA, USA). Membranes were incubated overnight
with primary antibodies and 1 h with appropriate HRP-
conjugated secondary antibodies and developed using Super-
signal West Pico chemoluminescent substrate (Thermo Sci-
entific, Waltham, MA, USA). Photodensitometric analysis was
performed using ImageJ software (U.S. National Institutes of
Health, Bethesda, MD, USA).
Immunofluorescence staining and confocal microscopy
Tissues (ear, cremaster muscle, and nerves) were dissected
and immunostained as described previously (13) and ana-
lyzed using a Zeiss LSM5 PASCAL confocal laser-scanning
microscope (Zeiss, Welwyn Garden City, UK) equipped with
Ar (ex: 488 nm) and HeNe (ex: 543 and 633 nm) lasers.
Multiple Z-stack images at a resolution of 1024  1024 were
acquired with oil immersion Plan-Apochromat 63  1.4 NA
or A-Plan 40  0.65 NA objectives and reconstructed in 3D
using the image processing software IMARIS (Bitplane, Zu-
rich, Switzerland). JAM-C and VE-cadherin levels in perineu-
ral cells and E-cadherin and claudin-19 in paranodes and SLIs
were quantified in 3D reconstructed images using IMARIS
software as described previously (22).
Hematological parameters
Circulating leukocytes and arterial blood pressure were quan-
tified as previously reported (19).
Behavioral experiments
Muscular strength was measured using a grip strength meter
(Linton Instrumentation, Norfolk, UK). Mice were allowed to
grip onto a wire and then were pulled by the tail in the
opposite direction. The forelimb grip strength preceding the
loss of grip was measured by a digital scale according to
the manufacturer’s unit of force (grams). Experiments were
performed in a blinded fashion, and sessions consisting of 3
trials with a 15-min recovery time were repeated on 3 differ-
ent days. Touch sensation in the hindpaws was assessed using
the Von Frey hair test. Animals were placed in clear plexiglass
boxes with plastic mesh flooring and allowed to acclimatize
for 15 min until exploratory behavior ceased. Graded Von
Frey hairs were applied to midplantar surface of the hind-
paws, and the withdrawal responses were measured. Mice
were considered to respond to the stimulus when hairs
produced 3 withdrawals in 5 trials. The experiments were
performed in a blinded fashion and repeated 3 times on
different days.
Carrageenan-induced paw edema
Mice received a subplantar injection of -carrageenan (500
g in 50 l; Sigma, St. Louis, MO, USA) or PBS as a control.
The paw volume was measured at different time points after
stimuli injection with a hydroplethysmometer equipped with
mouse paw adaptors (Ugo Basile, Varese, Italy).
Neuropeptide depletion
Neuropeptide depletion from sensory neurons was induced
in anesthetized mice by a single subcutaneous injection of
capsaicin (50 mg/kg, Sigma) in 10% ethanol, 10% Tween-80,
and PBS (27). Mice were allowed to recover for 3 d before
being used for experiments. Depletion of neuropeptides was
confirmed by immunofluorescence staining of mouse ears
(Supplemental Fig. S4B).
In vivo skin plasma extravasation assay
Evans blue (5% in saline; 5 l/g body weight) was injected
into the tail vein of anesthetized mice, and 5 and 20 min later,
mustard oil (5% in mineral oil) or vehicle was topically
applied onto the ears. Mice were sacrificed 30 min after the
initial dose. To measure plasma extravasation, the accumu-
lated Evans blue was eluted and quantified from the dissected
ears, as reported previously (22).
Electrophysiology
Mice were anesthetized with tribromoethanol (0.02 ml/g
body weight, i.p.) and kept warm under a heating lamp.
Sciatic nerve motor conduction velocity was obtained as
reported before (28).
Nerve morphology
Analysis of nerve semithin and ultrathin sections was con-
ducted as described previously (29); sections were examined
by light microscopy or electron microscopy (EM). Determi-
nation of g ratio on semithin sections was performed by
digitally tracing the inner and outer layers of myelinated
fibers using Leica Qwin software (Leica Microsystems, Wet-
zlar, Germany). The g ratio was calculated by dividing the
diameter of the inner circumference of the axon (without
myelin) by the diameter of the outer circumference of the
total fiber (including myelin).
Statistics
Data analysis was performed using the statistical software
GraphPad Prism 4 (GraphPad, San Diego, CA, USA). Results
are expressed as means  se, unless stated otherwise. Statis-
tical significance was assessed by Student’s t test, 1-way
ANOVA with Student-Newman-Keuls multiple comparison
test, or 2-way ANOVA with Bonferroni post hoc test as appro-
priate. Analysis of the withdrawal response and scatter plots
was assessed by Fisher’s exact test and Mann-Whitney test,
respectively. Values of P 	 0.05 were considered significant.
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RESULTS
JAM-C is expressed in a broad range of peripheral
nerves
In a recent study, we reported on the novel expression
of JAM-C in peripheral nerves, specifically localized to
SCs at junctions between adjoining myelin end loops
(13). As our previous work largely analyzed the expres-
sion profile of JAM-C in sciatic nerves, to extend these
findings we have now investigated and compared the
expression of JAM-C in fibers isolated from several
different types of nerves, namely the vagus (supplying
parasympathetic motor and sensory fibers) and the
saphenous and sural (supplying largely sensory nerve
fibers), as compared with the sciatic nerve (supplying a
mixture of motor and sensory fibers). For this purpose,
whole-mount teased fibers isolated from fixed nerve
samples were immunostained for JAM-C and collagen
IV (a component of the SC basement membrane) and
analyzed by confocal microscopy. The results show that
in all samples, nerve fibers expressed JAM-C in SCs, at
sites characteristic of junctional regions of noncompact
myelin (Fig. 1A), in line with our previous findings
(13). Junctional structures of SCs have been reported
to occur in 3 different locations of noncompact myelin,
i.e., the paranodal regions on either side of the nodes of
Ranvier, the SLIs, and the inner and outer mesaxons
(30), and our results show that JAM-C is expressed at
these sites in myelinated fibers of all nerves studied
(Fig. 1A). We also analyzed expression of JAM-C in the
dorsal root ganglia (DRG). Here JAM-C was not de-
tected in the neuronal cell bodies but in line with the
above was detected in paranodes of fibers stemming
from them within the DRG (Fig. 1B). Notably, JAM-C
was not detected on teased nonmyelinating SCs in
sciatic nerve (identified through the use of the
marker L1; Supplemental Fig. S1), confirming the
specific expression of this adhesion molecule in
myelinating SCs.
Expression of JAM-C in sensory and motor fibers
We next sought to investigate the expression of JAM-C
in more detail in different types of nerve fibers. For this
Figure 1. JAM-C expression in different nerves. A) Confocal images showing immunostaining of JAM-C and collagen IV in
whole-mounted teased fibers from sciatic (i, v), saphenous (ii, vi), sural (iii, vii), and vagus (iv, viii) nerves. In all nerves studied,
JAM-C was expressed at paranodal regions (arrows) on both side of the nodes of Ranvier, SLIs (arrowheads) and mesaxons
(double arrowheads). B) Dorsal root ganglia sections showed lack of JAM-C in the neuronal cell bodies (asterisks), but positive
expression was seen in paranodes of the fibers originating directly from them (arrows). Scale bars 
 10 m.
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purpose, we chose to investigate the profile and char-
acteristics of fibers in sciatic nerves, a nerve trunk that
contains a mixture of motor and sensory fibers, thus
enabling direct comparison of JAM-C expression in
multiple types of fibers. Sensory fibers were identified
through expression of the neuropeptide calcitonin
gene related peptide (CGRP). Immunofluorescence
staining of teased sciatic nerve fibers showed that 62.4%
of the CGRP fibers expressed JAM-C, confirming that
sensory fibers can be JAM-C (Fig. 2A). To characterize
the different type of fibers expressing JAM-C, sciatic
nerve teased fibers were classified into 3 populations
according to their diameter and the expression profile
of JAM-C/CGRP (Fig. 2B). The JAM-C/CGRP pop-
ulation of fibers showed an average diameter of 2.72 
0.11 m and highly likely comprise the slow-conducting
small unmyelinated sensory C fibers. JAM-C/CGRP
fibers showed an average diameter of 3.81  0.10 m,
highly characteristic of the medium-size finely myelin-
ated A sensory fibers. Finally, the JAM-C/CGRP
fibers exhibited a wider diameter distribution with an
average diameter of 7.58  0.18 m, which would
mostly include large motor fibers, as well as possibly a
population of A sensory fibers, which are negative for
CGRP, and the large A sensory fibers. Together, these
results indicate that JAM-C is expressed in both motor
and sensory myelinated fibers, which suggests that it
may be involved in the regulation of nociception
and/or neurogenic inflammation, issues that were ad-
dressed in subsequent studies detailed below.
Generation of mice with selective deletion of JAM-C
in SCs
To generate a clean model for investigation of JAM-C in
peripheral nerves, we developed mutant mice with
selective deletion of JAM-C in SCs. For this purpose,
homozygous mice for floxed JAM-C (25) were crossed
with transgenic mice hemizygous for protein 0 (P0)-
Cre, which activates Cre-mediated DNA recombination
of flanked lox-p regions specifically in SCs of peripheral
nerves (26), to finally produce the JAM-C SC KO mice.
Western blot (WB) of isolated sciatic, vagus, sural,
and saphenous nerves confirmed the lack of JAM-C
expression in peripheral nerves from JAM-C SC KO
mice as compared to wild-type (WT) control or
heterozygous littermates (Fig. 3A). The expression and
localization of JAM-C in whole-mount teased fibers
isolated from WT and JAM-C SC KO mouse sciatic
nerves was also investigated by immunofluorescent
staining and confocal microscopy. Samples were immu-
nostained for JAM-C, E-cadherin (a marker for adher-
ens junctions) and laminin 2 (a component of SC
basement membrane). Fibers from WT mice showed
the characteristic junctional expression of JAM-C, co-
localized with E-cadherin, in SCs (Fig. 3B). The
Figure 2. JAM-C is expressed in medium- but not
small-diameter murine sensory fibers. A) Expression
profiles of JAM-C and CGRP discriminate 3 subpopu-
lations of fibers in mouse sciatic nerves: JAM-C/
CGRP, unmyelinated small sensory C fibers (ar-
rowheads); JAM-C/CGRP, thinly myelinated A
sensory fibers (arrows); and JAM-C/CGRP, myelin-
ated fibers, including large motor fibers, a subset of A
fibers, and A fibers (double arrowheads). B) Diame-
ter distribution of the 3 fiber subpopulations de-
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JAM-C SC KO fibers showed no expression of JAM-C
but normal localization and expression of E-cadherin
and laminin 2.
The mutant mice were born at the expected mende-
lian ratio and, interestingly, in contrast to the severe
phenotype noted in the complete JAM-C-KO mice (10,
17, 19), the JAM-C SC KO mice were fertile, appeared
healthy, and did not develop megaoesophagus (Supple-
mental Fig. S2A, B). Furthermore, these mice did not
show any significant difference in their growth, hema-
tological parameters, or blood pressure, as compared to
littermate controls (Supplemental Fig. S2C, D).
SC-specific deletion of JAM-C reveals novel
expression of JAM-C in perineural cells
To determine whether the deletion of JAM-C in the
JAM-C SC KO mice was exclusively limited to SCs, the
expression of JAM-C in other cell types known to
express this molecule (i.e., endothelial and epithelial
cells) was investigated by immunofluorescent staining
and analysis by confocal microscopy of whole-mount
cremaster muscles. This skeletal muscle is well inner-
vated, is highly vascularized, and is encased in an
epithelial layer, thus enabling the expression of JAM-C
to be investigated in nerves, ECs, and epithelial cells in
the same tissue. Tissues from WT and JAM-C SC KO
mice showed comparable expression profiles of JAM-C
in blood vessels, where JAM-C was largely expressed at
junctions between adjacent ECs colocalized with other
EC junctional molecules; i.e., PECAM-1 and VE-cad-
herin (Fig. 4A). Cremaster muscles from WT and
mutant mice also showed similar expression of JAM-C
in epithelial cells, colocalized with JAM-A (Fig. 4B).
Of interest, and surprisingly, we noted that in tissues
from JAM-C SC KO mice, JAM-C was expressed at sites
associated with nerve bundles (Fig. 4C). Double stain-
ing of tissues for JAM-C and E-cadherin showed that
this JAM-C expression was not linked with SCs and was,
in fact, localized to junctions between adjacent perineu-
ral cells within the perineural sheath that surrounds
peripheral nerves (Fig. 4C, D). Using tissues from WT
mice, we previously reported on the expression of
JAM-A on perineural cells but not SCs (13). However,
as WT tissues express high levels of JAM-C on SCs, the
relatively lower expression of JAM-C on perineural cells
cannot readily be distinguished from that on SCs and
was, therefore, not noted in our previous investigations.
The difference in expression levels of JAM-C in these
two structures is clearly demonstrated in Fig. 4D, where,
at saturation image-acquisition settings in WT tissues,
the high JAM-C fluorescence signal detected in E-
cadherin SCs surrounding individual axons (indi-
cated by arrows) makes the detection of the low-
JAM-C-expressing perineural cells surrounding nerve
bundles (arrowheads) difficult. In the present study,
the availability of SC-specific JAM-C-KO mice enabled
us to observe and, for the first time, report on the
expression of JAM-C at junctions between adjacent
perineural cells. Indeed, costaining of JAM-C SC KO
cremaster muscle tissues for JAM-C and JAM-A illus-
trated the direct colocalization of these molecules in
the perineural sheath surrounding peripheral nerves
(Fig. 4E). Of note, detailed quantitative analysis showed
no significant differences between strains in the levels
of perineural cell JAM-C (Supplemental Fig. S3). Fi-
nally, the small contribution of perineural vs. SC JAM-C
to the total JAM-C content in isolated sciatic nerves was
also illustrated by WB (Fig. 4F), comparing the bands for
JAM-C in nerves from WT (expressing JAM-C in both SCs
and perineural cells) and JAM-C SC KO mice (expressing
JAM-C only in perineural cells). Notably, no band for
JAM-C was detected in sciatic nerves isolated from JAM-C
complete-KO mice (lacking JAM-C in both SCs and
perineural cells). Together, the findings show that dele-
tion of JAM-C in JAM-C SC KO mice is specific to SCs and
that the availability of these mice identified the previously
undetected expression of JAM-C in another component
of nerves, within the perineural sheath at junctions be-
tween adjacent perineural cells.
Figure 3. Characterization of SC-specific JAM-C-KO mice. A) WB analysis showed deletion of JAM-C as compared to
neurofilament-M (NF) in sciatic, sural, saphenous, and vagus nerves from JAM-C SC KO mice as compared to littermate WT or
heterozygous controls (5 g of homogenate protein was loaded). B) Analysis of sciatic nerve teased fibers by confocal
microscopy confirmed the deletion of JAM-C from SCs in JAM-C SC KO as compared to WT mice. Expression of E-cadherin and
laminin-2 showed no differences between strains. Scale bar 
 10 m.
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JAM-C SC KO mice exhibit neural function and
behavioral defects
To investigate potential defects in neuronal functions
of the JAM-C SC KO mice, we initially evaluated their
electrophysiological properties. Sciatic nerves from
JAM-C SC KO mice exhibited a small but significant
reduced conduction velocity after stimulation com-
pared to nerves from littermate controls (31.71.7 and
35.90.7 m/s, respectively; P	0.05 for n
8 nerves;
12% slower). This mild alteration in nerve function
was accompanied by a poorer performance of the
JAM-C SC KO mice in a behavioral test of muscular
strength (Fig. 5A). Because JAM-C is expressed in
sensory fibers (Fig. 2), we also investigated the potential
role of SC JAM-C in models of sensory nerve function.
Specifically, we investigated the phenotype of the
JAM-C SC KO mice in models of acute pain and
neurogenic inflammation. With respect to the former,
we analyzed the hindpaw withdrawal response of JAM-C
SC KO mice to static mechanical stimuli using cali-
brated Von Frey filaments, a well-characterized method
for measuring nociceptive reflex behavior. In this assay,
the JAM-C SC KO mice showed a significant increase in
the number of paw withdrawals in response to low-
intensity stimuli as compared to WT littermates (Fig.
5B), indicating mechanical hypersensitivity in the KOs.
To investigate the role of SC JAM-C in models of
neurogenic inflammation, we assessed mouse re-
sponses to the inflammatory stimuli carrageenan and
mustard oil, stimuli known to elicit sensory nerve-
mediated reactions (31, 32). In initial studies, induc-
tion of paw edema by subplantar injection of carra-
geenan was shown to have a C-fiber component
Figure 4. Expression of JAM-C in endothelial, epithelial, and perineural cells from JAM-C SC KO mice. A) Longitudinal (left
panels) and cross-sectional (right panels) confocal images of cremasteric venules showing normal expression of JAM-C at
junctions of ECs (stained for PECAM-1 and VE-cadherin) from JAM-C SC KO as compared to WT mice. B) Confocal images of
epithelial cells (stained for JAM-A) from JAM-C SC KO as compared to WT mice. C) Images of whole-mount cremaster muscles
from JAM-C SC KO mice demonstrated deletion of JAM-C from SC (stained for E-cadherin) in peripheral tissues. Unexpectedly,
JAM-C (arrowheads) was found to be expressed surrounding peripheral nerve bundles (n). Specific staining of JAM-C is shown
by the positive staining of microvascular ECs (v). D) Cross-section analysis of confocal images from cremasteric nerve bundles
showed expression of JAM-C at both perineural (arrowheads) and SCs (arrows) in WT animals, whereas JAM-C SC KO mice only
expressed JAM-C in perineural cells (arrowheads). E) Expression of JAM-C and JAM-A at junctions of perineural cells from
JAM-C SC KO mice. F) WB of sciatic nerves from WT, JAM-C SC KO, and JAM-C complete-KO mice (50 g of homogenate
protein was loaded). Neurofilament-M was used as a loading control. Scale bars 
 10 m.
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(Supplemental Fig. S4), as it was dependent on capsa-
icin-sensitive unmyelinated sensory neurons and on the
functional presence of TRPV1. TRPV1 is a receptor
mainly expressed in C fibers and involved in the release
of a number of inflammatory mediators (33). Both in
this model and in a model of skin plasma extravasation
as induced by topical application of mustard oil to the
ears, the JAM-C SC KO mice exhibited identical re-
sponses to those detected in littermate controls (Fig.
5C, D).
Collectively, the data indicate that the specific dele-
tion of JAM-C from SCs in peripheral nerves causes
mild motor and sensory function defects but no defects
in neurogenic inflammation. These results are in line
with the specific expression of JAM-C in different types
of nerve fibers; i.e., expression in motor fibers and A
but not sensory C fibers (Fig. 2).
JAM-C SC KO nerves exhibit mild morphological
defects
To investigate gross morphology of nerve fibers from
JAM-C SC KO mice, semithin cross sections of sciatic
nerves were analyzed by light microscopy (Fig. 6A).
Quantification of the acquired images showed no sig-
nificant differences between groups in the averaged g
ratios (0.660.04 and 0.660.03 for the WT and JAM-C
SC KO mice, respectively, with a total of 1161 and 1263
fibers analyzed from 4 animals/group) or in the scatter
plot of g ratios of individual fibers vs. axon diameters
(Fig. 6B). However, JAM-C SC KO mice exhibited a
significant decrease in the percentage of 3- to 4-m-
diameter fibers (Fig. 6C), while the distribution of the
axonal diameter was not altered between strains (Fig.
6D), suggesting that axon myelination defects in spe-
cific subpopulations of fibers may occur within the KO
sciatic nerves.
We next addressed the possibility that nerves from
the mutant mice may have disrupted expression profile
of key proteins involved in maintaining the structural
integrity and hence normal function of peripheral
nerve fibers. In this context, WB analysis of sciatic
nerves from JAM-C SC KO mice showed normal levels
of key adhesion molecules present in the SC myelin
compartment, such as E-cadherin, claudin-1, claudin-
19, and Mupp-1, as compared to WT nerves (Supple-
mental Fig. S5). Levels of the structural proteins neu-
rofilament-M and peripheral myelin-P0 were also
normal in the KO mice. Confocal microscopy analysis
of immunofluorescence-stained isolated sciatic nerve
fibers also showed normal distribution and localization
of E-cadherin, claudin-19, caspr, and Kv1.1 channel in
mutant sciatic nerve fibers (Fig. 3B and Supplemental
Figs. S6A and S7). In addition, exhaustive analysis of
E-cadherin and claudin-19 expression specifically in
paranodes and SLIs showed no differences in the levels
of these proteins within these specialized structures in
WT and KO nerves (Supplemental Fig. S6A, B). Also,
we found no differences between WT and JAM-C SC
KO nerves in the number of SLIs per millimeter of
sciatic nerve fiber [13.71.1 vs. 14.10.7 SLIs/mm, for
WT (1059 SLIs analyzed) and KO nerves (897 SLIs
Figure 5. JAM-C SC KO mice exhibit mild neural functional and behavioral
defects. A, B) JAM-C SC KO mice showed reduced grip strength (A) and
higher withdrawal response to Von Frey hairs (B) as compared to WT
controls (n
9 mice/group), indicating muscular weakness and mechanical
hypersensitivity, respectively. C, D) JAM-C SC KO mice showed no signifi-
cant differences as compared to WT in two models of neurogenic inflam-
mation: 24- and 48-h carrageenan-induced paw edema formation (C; n
8
mice/group) and mustard oil-induced ear skin plasma extravasation (D;
n
3–5 animals/group). *P 	 0.05; ***P	0.001.
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analyzed), respectively, n
3 mice/group] or in the
internodal length [70815 vs. 73942 m for KO
(n
67 fibers) and WT (n
58) fibers, respectively, with
n
3 mice/group].
Ultrastructural EM analysis of transverse sections of
sciatic and vagus nerves showed no significant defects
in the myelin structure of JAM-C SC KO fibers or in the
“kissing points” of tight junctions on the mesaxons as
compared to WT nerve fibers (data not shown). How-
ever, EM analysis of sciatic nerve longitudinal sections
revealed subtle defects in the alignment of sequential
paranodal terminal loops in JAM-C SC KO fibers as
compared to WT. Specifically, as compared to WTs, in
KO fibers a higher proportion of terminal loops exhib-
ited an apparent looser adhesion to adjacent loops and
the axon (5.2 and 13.0% of abnormal loops in WT and
SC KO, respectively, with 210 and 455 loops analyzed
from n
3 mice/group, P	0.01). Furthermore, this
apparent abnormality in paranodal terminal loops was
associated with a significant increase in the average
length of the nodes from JAM-C SC KO nerves as
compared to WT, as shown by EM analysis (Fig. 6E).
The morphology of the nodes of Ranvier was also
investigated in sciatic nerve teased fibers immunofluo-
rescently stained for anti-Nav channel and analyzed by
confocal microscopy. Analysis of images showed that,
although Nav channels remained tightly clustered at
the nodes (Fig. 6F), they occupied a longer portion of
the axolemma, confirming a significant increase in
nodal length (Fig. 6F). Collectively, the results indicate
that selective deletion of JAM-C from SCs results in
subtle defects in the paranode/node structure, a phe-
nomenon that may account for the neural dysfunctions
noted in JAM-C SC KO nerves and mice.
DISCUSSION
JAM-C is a cell adhesion molecule that to date has been
implicated in cell polarity and multiple inflammatory
and vascular responses (1, 2). Recent findings from our
group have also shown that JAM-C is expressed in
myelinated peripheral nerves, localized to SCs, and
plays a critical role in their integrity and function (13).
As the latter remains the only published work to date
reporting on the role of JAM-C in SCs, to further
investigate the functions of JAM-C in nerves here we
report on the generation of a novel mouse colony in
Figure 6. Neural morphology analysis of JAM-C SC KO mice. A) Representative images of transverse semithin sections of WT and
JAM-C SC KO sciatic nerve fibers. B) Scatter plot of g ratio according to axonal diameter of sciatic nerves from WT and JAM-C
SC KO mice. C, D) Distribution of sciatic nerve fiber (C) and axon (D) diameters from WT and JAM-C SC KO mice. E, F) Average
length of the node of Ranvier was quantified from WT and JAM-C SC KO mouse sciatic nerves by EM (E; n
19 and 30 nodes,
respectively, from 3 mice/group) and by confocal microscopy (F) with teased sciatic nerve fibers immunostained for Nav
channel and claudin-19 (n
113 and 109 nodes, respectively, from 3 mice/group). Scale bars 
 20 m (A); 2 m (E, F). *P 	
0.05; ***P 	 0.001.
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which JAM-C is deleted selectively in SCs, JAM-C SC
KO. The characterization and investigations of these
mice provided clear cut evidence for the involvement of
SC JAM-C in the fine organization of peripheral nerves
and in modulating multiple neuronal responses. In
addition, the present study characterizes the expression
of JAM-C on myelinated sensory fibers, and reports on
the previously undetected expression of JAM-C at cell-
cell junctions of perineural cells.
Axons exhibit elaborate interactions with myelinat-
ing glial cells; i.e., SCs in the peripheral nervous system
(PNS) and oligodendrocytes in the central nervous
system (CNS). These interactions involve the existence
of multiple polarized domains composed of numerous
cell adhesion/scaffolding molecules and ion channels
that collectively ensure rapid saltatory nerve conduc-
tion (30, 34). Specifically, glial cells wrap around axons
in such a way so as to provide electrical insulation of
segments of the axon that are separated by distinct,
noninsulated regions known as nodes of Ranvier (30,
34). These sites are rich in voltage-gated sodium chan-
nels, causing the action potential to be propagated
rapidly. To support efficient saltatory conduction, tight
interactions must exist between the axon and the glial
cells, both at regions that flank the nodes of Ranvier
(paranodal junctions) and between adjacent mem-
brane layers of individual glial cells. Compact myelin
seals the intermembranous spaces, whereas junctions
within noncompact myelin, which are found in the
outer and inner mesaxons, the SLIs, and the paranodal
regions, collectively seal the borders of the wrapped
glial cell and contribute to maintaining the integrity of
the myelin sheath. Detailed knowledge of the mole-
cules involved in forming junctions at these regions is
still lacking (30), but it is known that the complexes
include adherens junctions (composed of E-cadherin;
ref. 35) and gap junctions (composed of connexin 32;
ref. 36). Furthermore, EM studies have indicated the
existence of tight junctions (37, 38), and to date, a
number of claudin molecules have been identified at
these regions in both the CNS and PNS (39–41),
though recent studies have reported on some distinct
differences in expression of these molecules in human
and rodent SCs (42). In the present study, we analyzed
the expression profile of JAM-C in multiple large nerves
composed of different types of nerve fibers. Immuno-
fluorescent staining and confocal microscopy of iso-
lated sciatic, vagus, saphenous, and sural nerves, as well
as DRG sections, collectively demonstrated the expres-
sion of JAM-C in motor and sensory nerve fibers. Closer
analysis of expression of JAM-C in sensory nerve fibers
(detected through immunostaining for the neuropep-
tide CGRP) showed its presence on medium-size finely
myelinated A sensory fibers (mean diameter 4 m)
and, as anticipated, not on small sensory fibers (diam-
eter 2.5 m), representing unmyelinated C-fibers. In
all JAM-C fibers, JAM-C was expressed at paranodal
regions, SLIs, and the mesaxonal bands. The present
findings, in conjunction with our previous work (13),
make a significant contribution to the field by demon-
strating the existence of JAM-C in SCs at regions of
noncompact myelin in motor and sensory nerves of the
PNS, an expression profile that appears to hold true for
both human and mouse nerves. As JAM-C is an adhe-
sion molecule commonly localized at tight junctions,
our collective results have indicated that JAM-C is
expressed at tight junctions between the membrane
folds of individual SCs. Based on this expression pro-
file, it would be plausible to hypothesize a role for
JAM-C in maintaining the integrity, architecture, and
function of myelinated peripheral nerves, as discussed
below.
Analysis of KO animals is the most direct mode of
investigating the functional role of a molecule, espe-
cially within in vivo models. In line with this approach,
previous work from our laboratory investigated the role
of JAM-C in neural functions using JAM-C-KO mice
(13). These studies provided evidence for the involve-
ment of JAM-C in maintaining the integrity of the
myelin sheath, as indicated by structural and functional
defects in JAM-C-deficient peripheral nerves, as well as
behavioral motor abnormalities in these animals (13).
However, as JAM-C exhibits a broad cellular expression
profile, and JAM-C-KO animals have a severe pheno-
type (e.g., male infertility, a high mortality rate, growth
impairment, and immune defects; refs. 10, 17, 19, 23),
we considered it essential to extend our previous works
by investigating the functional role of SC JAM-C
through the development of conditional mice with
selective deletion of JAM-C in SCs. This approach
would rule out the potential interference of JAM-C
deletion in other cell types on neuronal functional
readouts. For this reason, JAM-C SC KO mice were
generated by Cre-mediated recombination using P0 as
the specific promoter for targeting SCs (26).
Initial characterization of JAM-C SC KO mice con-
firmed specific ablation of JAM-C in nerves and its lack
of expression at junctional sites in SCs. Furthermore no
evidence of compensatory mechanisms was noted, as
the protein level and/or localization of key molecules
implicated in maintaining the integrity and architec-
ture of myelinated peripheral nerves (e.g., E-cadherin,
claudin-1 and -19, Mupp-1, caspr and myelin-P0) ap-
peared to be normal. Of importance, contrary to the
severe phenotype of the full JAM-C-KO mice (10, 17,
19, 23), the JAM-C SC KO male mice were fertile, and
the crossing with JAM-Cwt/f females produced litters at
expected mendelian ratios. Mutant animals also ap-
peared healthy and did not show any differences in
their growth, size, weight, or hematological parameters,
as compared to littermate controls. Collectively, the
results indicate that SC JAM-C does not play a signifi-
cant role in notable characteristics of the full JAM-C-KO
mice, e.g., growth, development of megaoesophagus,
male sterility, and susceptibility to infections.
As part of the characterization studies of the JAM-C
SC KO mice, we noted normal expression of JAM-C at
junctions between adjacent endothelial and epithelial
cells but also identified, for the first time, the expres-
sion of JAM-C at contacts between perineural cells.
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These cells are the building blocks of the perineural
sheath that encase nerve bundles, and we have re-
ported previously on the expression of JAM-A on these
cells (13). The expression of JAM-C on perineural cells
was not noted in our earlier works or when initially
performing WB analysis of nerve samples due to its
relatively low expression as compared to the levels
expressed on SCs, an issue that was overcome with the
availability of nerve samples from JAM-C SC KO mice.
The novel identification of JAM-C at regions between
adjacent perineural cells, in addition to the expression
of JAM-A, is highly supportive of the existence of bona
fide intercellular junctions defining the contact points
between neighboring perineural cells, as suggested by
early electron microscopists (43). The existence of
JAMs in the perineural sheath suggests a role for these
molecules in maintaining the barrier function of this
structure, as well as possibly contributing to its integrity,
normal cellular functions (e.g., generation of basement
membrane) and polarity. Deletion of JAM-C from this
protective sheath in the full JAM-C-KO mice may have
contributed to some of the neuronal defects observed
in these mice (13), strengthening the argument for a
need for investigations of neural functions in the JAM-C
SC KO mice.
Functional analysis showed that compared to WTs,
JAM-C SC KO mice exhibited mild muscular weak-
ness as well as reduced sciatic nerve conduction
velocity. Overall, the noted defects were milder than
those quantified in JAM-C complete-KO mice (13),
which suggests that the absence of JAM-C in other
cells (e.g., perineural cells) may have contributed to
the observed neuronal defects of the full-KO animals.
Of relevance, mice deficient in SC-derived desert
hedgehog exhibit defective nerve-tissue barrier due
to abnormal junctions between adjacent perineural
cells, resulting in enhanced permeability of this
barrier to proteins and neutrophils (44). Defective
barrier function of the perineural sheath may com-
promise the integrity and hence function of the
“vulnerable” exposed encased nerves, rendering
nerves more susceptible to trauma.
Since JAM-C was detected on myelinated sensory
nerves, we also tested the JAM-C SC KO mice in
models of nociceptive reflex behavior and neuro-
genic inflammation. Specifically, by measuring the
withdrawal response to mechanical stimuli using
calibrated Von Frey hairs, JAM-C SC KO mice exhib-
ited an exaggerated response to lower stimuli as
compared to littermate controls, indicating mechan-
ical hypersensitivity in the mutants, but responded
normally in two inflammation models. These results
are in line with our findings indicating expression of
JAM-C on myelinated A sensory fibers, known to be
involved in nociception (45), and not on unmyeli-
nated C fibers, implicated in development of neuro-
genic edema and leukocyte infiltration. Overall, the
present results demonstrate that through its expres-
sion in both motor and sensory myelinated periph-
eral nerve fibers, JAM-C mediates muscle control and
processing of pain signals.
Finally, in investigating the mechanisms through
which SC JAM-C may be supporting normal neuronal
functions, we hypothesized that its presence was critical
in maintaining the structure and development of nor-
mal polarized domains within peripheral nerves. How-
ever, exhaustive analysis of the morphology of nerve
fibers from JAM-C SC KO mice failed to show any
detectable defects of tight junctions within SCs that are
important for intermembraneous sealing of the glial
cells and hence maintaining the integrity of the myelin
sheath. However, nerves from JAM-C SC KO mice
showed mild defects in the alignment of their paran-
odal terminal loops and increased length of the nodes
of Ranvier, as compared to WTs. Such abnormalities
may account for the defective neural functions ob-
served in the mutants, as increased nodal length has
been reported in several genetically modified mouse
strains that exhibit defects in the paranodal region
(46), including caspr-null mice, which also exhibit
neural dysfunction (47). Hence, it appears that absence
of SC JAM-C results in loose adhesion of terminal
paranodal loops to adjacent loops, in line with our
previous findings using the complete JAM-C-KO mice
(13), and that this defect causes increased nodal length
that can underlie defective nerve conduction.
In summary, our studies to date have presented
evidence for the expression of JAM-C at junctional sites
in the perineural sheath that provides a barrier and
protective coverage of nerve bundles, as well as JAM-C
expression at autotypic junctions between the paran-
odal loops of SCs in both motor and myelinated sensory
nerve fibers. Furthermore, through the generation and
use of conditional-KO mice with specific deletion of
JAM-C in SCs, we provide conclusive evidence for the
involvement of SC JAM-C in regulation of neural func-
tions and acute mechanical pain, rendering these mice
a valuable tool for further investigations of the func-
tions of JAM-C in peripheral nerves and in the patho-
physiology of peripheral neuropathies. Finally, as nu-
merous mutations are causally linked with different
forms of inherited neuropathies, our findings suggest a
need for detailed investigations into associations of
potential JAM-C mutations with neural disease. To our
knowledge, to date no such investigations have taken
place with respect to peripheral neuropathies, though,
of interest, genome-wide association studies have iden-
tified JAM-C as a candidate gene for bipolar disorder
(48, 49), which suggests a broader role for JAM-C in
neurological functions and disorders.
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